{"address1": "2100 Wharton Street", "address2": "Suite 701", "city": "Pittsburgh", "state": "PA", "zip": "15203", "country": "United States", "phone": "412 586 5830", "website": "https://www.krystalbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 275, "companyOfficers": [{"maxAge": 1, "name": "Mr. Krish S. Krishnan M.B.A., M.S.", "age": 59, "title": "Founder, Chairman, President & CEO", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 1323633, "exercisedValue": 0, "unexercisedValue": 2138577}, {"maxAge": 1, "name": "Ms. Suma M. Krishnan", "age": 59, "title": "Founder, President of R&D and Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 895325, "exercisedValue": 0, "unexercisedValue": 1718496}, {"maxAge": 1, "name": "Ms. Kathryn A. Romano CPA", "age": 43, "title": "Executive VP & Chief Accounting Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 614867, "exercisedValue": 2348054, "unexercisedValue": 663999}, {"maxAge": 1, "name": "Mr. John  Thomas", "title": "General Counsel & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Karakkal", "title": "Vice President of North American Sales & Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Christine  Wilson", "title": "Head of U.S. Sales & Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephane  Paquette Ph.D.", "title": "Vice President of Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Josh  Suskin", "title": "Senior Director & Head of US Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Laurent  Goux", "title": "Senior VP & GM of Europe", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Chien", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 6, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 180.3, "open": 178.675, "dayLow": 173.68, "dayHigh": 181.445, "regularMarketPreviousClose": 180.3, "regularMarketOpen": 178.675, "regularMarketDayLow": 173.68, "regularMarketDayHigh": 181.445, "payoutRatio": 0.0, "beta": 0.869, "trailingPE": 58.193333, "forwardPE": 29.842735, "volume": 307491, "regularMarketVolume": 307491, "averageVolume": 266710, "averageVolume10days": 252440, "averageDailyVolume10Day": 252440, "bid": 173.3, "ask": 175.55, "bidSize": 3, "askSize": 3, "marketCap": 5028968960, "fiftyTwoWeekLow": 141.72, "fiftyTwoWeekHigh": 219.34, "priceToSalesTrailing12Months": 17.310532, "fiftyDayAverage": 171.8899, "twoHundredDayAverage": 179.62656, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4438709248, "profitMargins": 0.3069, "floatShares": 22823920, "sharesOutstanding": 28806100, "sharesShort": 2701192, "sharesShortPriorMonth": 3186586, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0938, "heldPercentInsiders": 0.12239, "heldPercentInstitutions": 1.05948, "shortRatio": 8.69, "shortPercentOfFloat": 0.1236, "impliedSharesOutstanding": 29435000, "bookValue": 32.867, "priceToBook": 5.311711, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": 4.232, "netIncomeToCommon": 89159000, "trailingEps": 3.0, "forwardEps": 5.85, "enterpriseToRevenue": 15.279, "enterpriseToEbitda": 42.009, "52WeekChange": -0.018496633, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 174.58, "targetHighPrice": 245.0, "targetLowPrice": 195.0, "targetMeanPrice": 214.8, "targetMedianPrice": 215.0, "recommendationKey": "none", "numberOfAnalystOpinions": 10, "totalCash": 597516992, "totalCashPerShare": 20.743, "ebitda": 105662000, "totalDebt": 7261000, "quickRatio": 6.885, "currentRatio": 7.275, "totalRevenue": 290515008, "debtToEquity": 0.767, "revenuePerShare": 10.161, "returnOnAssets": 0.06883, "returnOnEquity": 0.103369996, "grossProfits": 270454016, "freeCashflow": 92960872, "operatingCashflow": 123420000, "earningsGrowth": 4.095, "revenueGrowth": 1.163, "grossMargins": 0.93095, "ebitdaMargins": 0.36371, "operatingMargins": 0.45402, "financialCurrency": "USD", "symbol": "KRYS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1505914200000, "preMarketChange": 0.0, "preMarketChangePercent": 0.0, "preMarketPrice": 174.58, "marketState": "PRE", "regularMarketChangePercent": -3.1724908, "regularMarketPrice": 174.58, "shortName": "Krystal Biotech, Inc.", "longName": "Krystal Biotech, Inc.", "regularMarketChange": -5.720001, "regularMarketDayRange": "173.68 - 181.445", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 266710, "fiftyTwoWeekLowChange": 32.86, "fiftyTwoWeekLowChangePercent": 0.23186566, "fiftyTwoWeekRange": "141.72 - 219.34", "fiftyTwoWeekHighChange": -44.759995, "fiftyTwoWeekHighChangePercent": -0.20406672, "fiftyTwoWeekChangePercent": -1.8496633, "earningsTimestamp": 1739966400, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1739971800, "earningsCallTimestampEnd": 1739971800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 3.0, "epsForward": 5.85, "epsCurrentYear": 7.57835, "priceEpsCurrentYear": 23.036676, "fiftyDayAverageChange": 2.6901093, "fiftyDayAverageChangePercent": 0.015650189, "twoHundredDayAverageChange": -5.0465546, "twoHundredDayAverageChangePercent": -0.028094701, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "corporateActions": [], "preMarketTime": 1743590064, "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_534062888", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Krystal Biotech", "trailingPegRatio": null}